Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

BACKGROUND The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape of lung-cancer screening, with studies indicating that low-dose CT detects many tumors at early stages. The National Lung Screening Trial (NLST) was conducted to determine whether screening with low-dose CT could reduce mortality from lung cancer. METHODS From August 2002 through April 2004, we enrolled 53,454 persons at high risk for lung cancer at 33 U.S. medical centers. Participants were randomly assigned to undergo three annual screenings with either low-dose CT (26,722 participants) or single-view posteroanterior chest radiography (26,732). Data were collected on cases of lung cancer and deaths from lung cancer that occurred through December 31, 2009. RESULTS The rate of adherence to screening was more than 90%. The rate of positive screening tests was 24.2% with low-dose CT and 6.9% with radiography over all three rounds. A total of 96.4% of the positive screening results in the low-dose CT group and 94.5% in the radiography group were false positive results. The incidence of lung cancer was 645 cases per 100,000 person-years (1060 cancers) in the low-dose CT group, as compared with 572 cases per 100,000 person-years (941 cancers) in the radiography group (rate ratio, 1.13; 95% confidence interval [CI], 1.03 to 1.23). There were 247 deaths from lung cancer per 100,000 person-years in the low-dose CT group and 309 deaths per 100,000 person-years in the radiography group, representing a relative reduction in mortality from lung cancer with low-dose CT screening of 20.0% (95% CI, 6.8 to 26.7; P=0.004). The rate of death from any cause was reduced in the low-dose CT group, as compared with the radiography group, by 6.7% (95% CI, 1.2 to 13.6; P=0.02). CONCLUSIONS Screening with the use of low-dose CT reduces mortality from lung cancer. (Funded by the National Cancer Institute; National Lung Screening Trial ClinicalTrials.gov number, NCT00047385.).

[1]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[2]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  D. McCauley,et al.  Low-dose CT of the lungs: preliminary observations. , 1990, Radiology.

[4]  G. Petersen,et al.  Epidemiology, screening, and prevention of lung cancer. , 1994, Current opinion in oncology.

[5]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[6]  KyungMann Kim.  Group Sequential Methods with Applications to Clinical Trials , 2001 .

[7]  C. Begg,et al.  The influence of hospital volume on survival after resection for lung cancer. , 2001, The New England journal of medicine.

[8]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[9]  T. Church.  Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. , 2003, Academic radiology.

[10]  J. Austin,et al.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. , 2005, Radiology.

[11]  J Anthony Seibert,et al.  Description and implementation of a quality control program in an imaging-based clinical trial. , 2006, Academic radiology.

[12]  J. Habbema,et al.  Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON) , 2007, International journal of cancer.

[13]  P. Prorok,et al.  Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. , 2007, American journal of epidemiology.

[14]  Kwang Pyo Kim,et al.  Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk , 2008, Journal of medical screening.

[15]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[16]  M. Mahesh,et al.  Slice wars vs dose wars in multiple-row detector CT. , 2009, Journal of the American College of Radiology : JACR.

[17]  A. Dirksen,et al.  The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  Harry J de Koning,et al.  Management of lung nodules detected by volume CT scanning. , 2009, The New England journal of medicine.

[19]  Eugenio Paci,et al.  Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. , 2009, Lung cancer.

[20]  Kavita Garg,et al.  CT quality assurance in the lung screening study component of the National Lung Screening Trial: implications for multicenter imaging trials. , 2009, AJR. American journal of roentgenology.

[21]  Ugo Pastorino,et al.  Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. , 2009, Radiology.

[22]  A. Malarcher,et al.  Cigarette smoking among adults and trends in smoking cessation - United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[23]  Armando Santoro,et al.  A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. , 2009, American journal of respiratory and critical care medicine.

[24]  H. Welch,et al.  Overdiagnosis in cancer. , 2010, Journal of the National Cancer Institute.

[25]  F. Hirsch,et al.  Lung Cancer: A multidisciplinary Approach to Diagnosis and Management , 2010 .

[26]  Denise R. Aberle,et al.  Baseline Characteristics of Participants in the Randomized National Lung Screening Trial , 2010, Journal of the National Cancer Institute.

[27]  M. Albitar,et al.  Somatic mutations of signaling genes in non-small-cell lung cancer. , 2010, Cancer genetics and cytogenetics.

[28]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[29]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[30]  D. Lynch,et al.  The National Lung Screening Trial: overview and study design. , 2011, Radiology.

[31]  H. Sox.  Better evidence about screening for lung cancer. , 2011, The New England journal of medicine.

[32]  M. White,et al.  Prevalence of heavy smoking in California and the United States, 1965-2007. , 2011, JAMA.

[33]  Jame Abraham,et al.  Reduced lung cancer mortality with low-dose computed tomographic screening , 2011 .

[34]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[35]  G. Izmirlian.  Estimation of the relative risk following group sequential procedure based upon the weighted log-rank statistic , 2011, 1102.5088.

[36]  N J Wald,et al.  UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer , 2011, Thorax.

[37]  L. Tanoue.  Baseline Characteristics of Participants in the Randomized National Lung Screening Trial , 2012 .